ABT

SEC source: 0001179110-10-003577 · edgar.xml · nonDerivative · entry 1

MAZZO JAMES V · CIK 0001227297 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,600

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003578 · edgar.xml · derivative · entry 4

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

Underlying: Common Shares · 28,700 shares

Expires 2020-02-18

F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 02/19/2011, 9,566 on 02/19/2012, and 9,567 on 02/19/2013.

SEC source: 0001179110-10-003578 · edgar.xml · nonDerivative · entry 2

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,465

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003578 · edgar.xml · nonDerivative · entry 1

LINDER GREG W · CIK 0001239128 · Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,465

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003580 · edgar.xml · derivative · entry 5

Warmuth Michael J · CIK 0001452290 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common shares · 33,500 shares

Expires 2020-02-18

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,167 on 2/19/2011, 11,166 on 2/19/2012, and 11,167 on 2/19/2013.

SEC source: 0001179110-10-003580 · edgar.xml · nonDerivative · entry 2

Warmuth Michael J · CIK 0001452290 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,477

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003580 · edgar.xml · nonDerivative · entry 1

Warmuth Michael J · CIK 0001452290 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,477

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003581 · edgar.xml · derivative · entry 4

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

Underlying: Common shares · 28,700 shares

Expires 2020-02-18

F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 2/19/2011, 9,566 on 2/19/2012, and 9,567 on 2/19/2013.

SEC source: 0001179110-10-003581 · edgar.xml · nonDerivative · entry 2

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,495

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003581 · edgar.xml · nonDerivative · entry 1

Szela Mary T · CIK 0001410289 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,495

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003585 · edgar.xml · derivative · entry 6

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

Underlying: Common shares · 28,700 shares

Expires 2020-02-18

F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 02/19/2011, 9,566 on 02/19/2012, and 9,567 on 02/19/2013.

SEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 4

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 160

F6 · shares: These shares represent restricted stock units granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program. The units vest in three equal annual installments on the anniversary of their grant date.

F5 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his spouse.

SEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 2

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,033

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

F3 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order.

SEC source: 0001179110-10-003585 · edgar.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,033

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F3 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order.

SEC source: 0001179110-10-003587 · edgar.xml · derivative · entry 6

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

Underlying: Common shares · 28,700 shares

Expires 2020-02-18

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 2/19/2011, 9,566 on 2/19/2012, and 9,567 on 2/19/2013.

SEC source: 0001179110-10-003587 · edgar.xml · nonDerivative · entry 2

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,851

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003587 · edgar.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,851

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003588 · edgar.xml · derivative · entry 3

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,000

Underlying: Common shares · 58,000 shares

Expires 2020-02-18

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,334 on 02/19/2011, 19,333 on 02/19/2012, and 19,333 on 02/19/2013.

SEC source: 0001179110-10-003588 · edgar.xml · nonDerivative · entry 2

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,442

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003588 · edgar.xml · nonDerivative · entry 1

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,442

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003589 · edgar.xml · derivative · entry 6

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

Underlying: Common shares · 28,700 shares

Expires 2020-02-18

F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 02/19/2011, 9,566 on 02/19/2012, and 9,567 on 02/19/2013.

SEC source: 0001179110-10-003589 · edgar.xml · nonDerivative · entry 2

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,409

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003589 · edgar.xml · nonDerivative · entry 1

Landgraf John C · CIK 0001298968 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,409

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003590 · edgar.xml · derivative · entry 7

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,100

Underlying: Common shares · 87,100 shares

Expires 2020-02-18

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,034 on 02/19/2011, 29,033 on 02/19/2012, and 29,033 on 02/19/2013.

SEC source: 0001179110-10-003590 · edgar.xml · nonDerivative · entry 2

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,260

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003590 · edgar.xml · nonDerivative · entry 1

FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 387,260

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003591 · edgar.xml · derivative · entry 6

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,900

Underlying: Common shares · 46,900 shares

Expires 2020-02-18

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,634 on 2/19/2011, 15,633 on 2/19/2012, and 15,633 on 2/19/2013.

SEC source: 0001179110-10-003591 · edgar.xml · nonDerivative · entry 2

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,342

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003591 · edgar.xml · nonDerivative · entry 1

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,342

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003592 · edgar.xml · derivative · entry 3

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,900

Underlying: Common Shares · 46,900 shares

Expires 2020-02-18

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,634 on 02/19/11, 15,633 on 02/19/12, and 15,633 on 02/19/13.

SEC source: 0001179110-10-003592 · edgar.xml · nonDerivative · entry 2

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,940

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003592 · edgar.xml · nonDerivative · entry 1

Michael Edward L · CIK 0001391823 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,940

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003593 · edgar.xml · nonDerivative · entry 2

ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,473

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003593 · edgar.xml · nonDerivative · entry 1

ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,473

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003595 · edgar.xml · derivative · entry 3

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,700

Underlying: Common Shares · 28,700 shares

Expires 2020-02-18

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 2/19/2011, 9,566 on 2/19/2012, and 9,567 on 2/19/2013.

SEC source: 0001179110-10-003595 · edgar.xml · nonDerivative · entry 2

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,199

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003595 · edgar.xml · nonDerivative · entry 1

Mason Heather L · CIK 0001432601 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,199

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003596 · edgar.xml · derivative · entry 4

Hance Robert B · CIK 0001383841 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common Shares · 33,500 shares

Expires 2020-02-18

F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,167 on 2/19/2011, 11,166 on 2/19/2012, and 11,167 on 2/19/2013.

SEC source: 0001179110-10-003596 · edgar.xml · nonDerivative · entry 2

Hance Robert B · CIK 0001383841 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,710

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003596 · edgar.xml · nonDerivative · entry 1

Hance Robert B · CIK 0001383841 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,710

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003597 · edgar.xml · derivative · entry 3

CAPEK JOHN M · CIK 0001328034 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,900

Underlying: Common Shares · 46,900 shares

Expires 2020-02-18

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,634 on 02/19/2011, 15,633 on 02/19/2012, and 15,633 on 02/19/2013.

SEC source: 0001179110-10-003597 · edgar.xml · nonDerivative · entry 2

CAPEK JOHN M · CIK 0001328034 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,055

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003597 · edgar.xml · nonDerivative · entry 1

CAPEK JOHN M · CIK 0001328034 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,055

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003598 · edgar.xml · derivative · entry 5

ALBAN CARLOS · CIK 0001474632 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,600

Underlying: Common shares · 34,600 shares

Expires 2020-02-18

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,534 on 02/19/2011, 11,533 on 02/19/2012, and 11,533 on 02/19/2013.

SEC source: 0001179110-10-003598 · edgar.xml · nonDerivative · entry 2

ALBAN CARLOS · CIK 0001474632 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,958

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003598 · edgar.xml · nonDerivative · entry 1

ALBAN CARLOS · CIK 0001474632 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,958

F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001179110-10-003599 · edgar.xml · derivative · entry 2

Bohuon Olivier · CIK 0001360215 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,900

Underlying: Common shares · 46,900 shares

Expires 2020-02-18

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,634 on 02/19/2011, 15,633 on 02/19/2012, and 15,633 on 02/19/2013.

SEC source: 0001179110-10-003599 · edgar.xml · nonDerivative · entry 1

Bohuon Olivier · CIK 0001360215 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,176

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program. The units generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Each unit represents the contingent right to receive one Abbott common share.

SEC source: 0001179110-10-003600 · edgar.xml · derivative · entry 4

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,600

Underlying: Common Shares · 34,600 shares

Expires 2020-02-18

F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,534 on 2/19/2011, 11,533 on 2/19/2012, and 11,533 on 2/19/2013.

SEC source: 0001179110-10-003600 · edgar.xml · nonDerivative · entry 2

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,385

F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.